Cerebrosterol

Cerebrosterol is a lipid of Sterol Lipids (ST) class. Cerebrosterol is associated with abnormalities such as nervous system disorder, Neurodegenerative Disorders, Alzheimer's Disease, Senile Plaques and Hypercholesterolemia. The involved functions are known as Blood - brain barrier function, Oxidation, 5-(carboxyamino)imidazole ribonucleotide mutase activity, cholesterol biosynthetic process and Anabolism. Cerebrosterol often locates in Hepatic, Body tissue, Autosome, brain tissue surgical material and Tissue membrane. The associated genes with Cerebrosterol are CYP27A1 gene, Alleles, INS gene, Apolipoprotein E4 and PLXNB1 gene. The related lipids are Sterols, 7-dehydrocholesterol, 27-hydroxycholesterol, 24-hydroxycholesterol and Dehydrocholesterols. The related experimental models are Mouse Model.

Cross Reference

Introduction

To understand associated biological information of Cerebrosterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Cerebrosterol?

Cerebrosterol is suspected in Hypercholesterolemia, nervous system disorder, Neurodegenerative Disorders, Alzheimer's Disease, Primary open angle glaucoma, Hypertensive disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Cerebrosterol

MeSH term MeSH ID Detail
Alzheimer Disease D000544 76 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Nerve Degeneration D009410 53 associated lipids
Plaque, Amyloid D058225 19 associated lipids
Total 4

PubChem Associated disorders and diseases

What pathways are associated with Cerebrosterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Cerebrosterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Cerebrosterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Cerebrosterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Cerebrosterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Cerebrosterol?

Mouse Model

Mouse Model are used in the study 'Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation.' (Valenza M et al., 2007).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Cerebrosterol

Download all related citations
Per page 10 20 50 100 | Total 193
Authors Title Published Journal PubMed Link
pmid:
Lütjohann D Cholesterol metabolism in the brain: importance of 24S-hydroxylation. 2006 Acta Neurol. Scand., Suppl.c pmid:16866909
Björkhem I et al. Oxysterols and Alzheimer's disease. 2006 Acta Neurol. Scand., Suppl.c pmid:16866910
Fourgeux C et al. Steady-state levels of retinal 24S-hydroxycholesterol are maintained by glial cells intervention after elevation of intraocular pressure in the rat. 2012 Acta Ophthalmol pmid:22998629
Lütjohann D et al. Cholesterol dynamics in the foetal and neonatal brain as reflected by circulatory levels of 24S-hydroxycholesterol. 2001 Acta Paediatr. pmid:11440099
Gamba P et al. Interaction between 24-hydroxycholesterol, oxidative stress, and amyloid-β in amplifying neuronal damage in Alzheimer's disease: three partners in crime. 2011 Aging Cell pmid:21272192
Gamba P et al. Up-regulation of β-amyloidogenesis in neuron-like human cells by both 24- and 27-hydroxycholesterol: protective effect of N-acetyl-cysteine. 2014 Aging Cell pmid:24612036
Serrano-Pozo A et al. Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers. 2010 Jul-Sep Alzheimer Dis Assoc Disord pmid:20473136
DeBarber AE et al. Liquid chromatography-tandem mass spectrometry determination of plasma 24S-hydroxycholesterol with chromatographic separation of 25-hydroxycholesterol. 2008 Anal. Biochem. pmid:18555788
Raina A and Kaul D LXR-α genomics programmes neuronal death observed in Alzheimer's disease. 2010 Apoptosis pmid:20927647
Locatelli S et al. Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain. 2002 Arch. Neurol. pmid:11843691
Vega GL et al. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease. 2003 Arch. Neurol. pmid:12707064
Papassotiropoulos A et al. Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. 2003 Arch. Neurol. pmid:12533085
Björkhem I and Meaney S Brain cholesterol: long secret life behind a barrier. 2004 Arterioscler. Thromb. Vasc. Biol. pmid:14764421
Khenjanta C et al. Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression. 2014 Asian Pac. J. Cancer Prev. pmid:25556446
Burkard I et al. Lipoprotein distribution and biological variation of 24S- and 27-hydroxycholesterol in healthy volunteers. 2007 Atherosclerosis pmid:17107679
Leoni V and Caccia C Study of cholesterol metabolism in Huntington's disease. 2014 Biochem. Biophys. Res. Commun. pmid:24525128
Fourgeux C et al. In vivo consequences of cholesterol-24S-hydroxylase (CYP46A1) inhibition by voriconazole on cholesterol homeostasis and function in the rat retina. 2014 Biochem. Biophys. Res. Commun. pmid:24491555
Meljon A et al. Oxysterols in the brain of the cholesterol 24-hydroxylase knockout mouse. 2014 Biochem. Biophys. Res. Commun. pmid:24491562
Baila-Rueda L et al. Bile acid synthesis precursors in familial combined hyperlipidemia: the oxysterols 24S-hydroxycholesterol and 27-hydroxycholesterol. 2014 Biochem. Biophys. Res. Commun. pmid:24406166
Famer D et al. Regulation of alpha- and beta-secretase activity by oxysterols: cerebrosterol stimulates processing of APP via the alpha-secretase pathway. 2007 Biochem. Biophys. Res. Commun. pmid:17532301
Gabbi C et al. Action mechanisms of Liver X Receptors. 2014 Biochem. Biophys. Res. Commun. pmid:24300092
Noguchi N et al. Diverse functions of 24(S)-hydroxycholesterol in the brain. 2014 Biochem. Biophys. Res. Commun. pmid:24530911
Zhang J et al. Metabolism of 27-, 25- and 24-hydroxycholesterol in rat glial cells and neurons. 1997 Biochem. J. pmid:9078259
Leoni V and Caccia C Potential diagnostic applications of side chain oxysterols analysis in plasma and cerebrospinal fluid. 2013 Biochem. Pharmacol. pmid:23541982
Watanabe K et al. Dual roles of nuclear receptor liver X receptor α (LXRα) in the CYP3A4 expression in human hepatocytes as a positive and negative regulator. 2013 Biochem. Pharmacol. pmid:23732298
Mast N et al. Broad substrate specificity of human cytochrome P450 46A1 which initiates cholesterol degradation in the brain. 2003 Biochemistry pmid:14640697
Liao WL et al. Steroid and protein ligand binding to cytochrome P450 46A1 as assessed by hydrogen-deuterium exchange and mass spectrometry. 2009 Biochemistry pmid:19317426
Russell DW Oxysterol biosynthetic enzymes. 2000 Biochim. Biophys. Acta pmid:11111082
Meaney S et al. Formation of oxysterols from different pools of cholesterol as studied by stable isotope technique: cerebral origin of most circulating 24S-hydroxycholesterol in rats, but not in mice. 2000 Biochim. Biophys. Acta pmid:10903480
Saucier SE et al. Hepatic uptake and metabolism of ingested 24-hydroxycholesterol and 24(S),25-epoxycholesterol. 1993 Biochim. Biophys. Acta pmid:8431485
Leoni V and Caccia C The impairment of cholesterol metabolism in Huntington disease. 2015 Biochim. Biophys. Acta pmid:25596342
Wang Y et al. A second class of nuclear receptors for oxysterols: Regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol). 2010 Biochim. Biophys. Acta pmid:20211758
Babiker A and Diczfalusy U Transport of side-chain oxidized oxysterols in the human circulation. 1998 Biochim. Biophys. Acta pmid:9630709
Lund E et al. 24-, 25- and 27-hydroxylation of cholesterol by a purified preparation of 27-hydroxylase from pig liver. 1993 Biochim. Biophys. Acta pmid:8443234
Leoni V and Caccia C 24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases. 2013 Biochimie pmid:23041502
Khripach VA et al. [A new synthesis of cerebrosterol and its 24-epimer from lithocholic acid]. 2007 Mar-Apr Bioorg. Khim. pmid:17476989
Bang HJ et al. A comparison of the potential unfavorable effects of oxycholesterol and oxyphytosterol in mice: different effects, on cerebral 24S-hydroxychoelsterol and serum triacylglycerols levels. 2008 Biosci. Biotechnol. Biochem. pmid:19060413
Zuliani G et al. Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study. 2011 BMC Neurol pmid:21970714
Bandaru VV and Haughey NJ Quantitative detection of free 24S-hydroxycholesterol, and 27-hydroxycholesterol from human serum. 2014 BMC Neurosci pmid:25539717
Leoni V et al. Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease. 2008 Brain pmid:18772220
Weiner MF et al. Plasma 24S-hydroxycholesterol and other oxysterols in acute closed head injury. 2008 Brain Inj pmid:18568715
Cartagena CM et al. 24S-hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injury. 2010 Brain Res. pmid:20053345
Saint-Pol J et al. Oxysterols decrease apical-to-basolateral transport of Aß peptides via an ABCB1-mediated process in an in vitro Blood-brain barrier model constituted of bovine brain capillary endothelial cells. 2013 Brain Res. pmid:23603412
Kölsch H et al. The neurotoxic effect of 24-hydroxycholesterol on SH-SY5Y human neuroblastoma cells. 1999 Brain Res. pmid:9914453
Yamanaka K et al. Induction of apoptosis and necroptosis by 24(S)-hydroxycholesterol is dependent on activity of acyl-CoA:cholesterol acyltransferase 1. 2014 Cell Death Dis pmid:24407243
Chen W et al. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. 2007 Cell Metab. pmid:17189208
Fourgeux C et al. 24S-hydroxycholesterol and cholesterol-24S-hydroxylase (CYP46A1) in the retina: from cholesterol homeostasis to pathophysiology of glaucoma. 2011 Chem. Phys. Lipids pmid:21531213
Gambert S et al. Cholesterol metabolism and glaucoma: Modulation of Muller cell membrane organization by 24S-hydroxycholesterol. 2017 Chem. Phys. Lipids pmid:28576383
Bezine M et al. Evidence of K homeostasis disruption in cellular dysfunction triggered by 7-ketocholesterol, 24S-hydroxycholesterol, and tetracosanoic acid (C24:0) in 158N murine oligodendrocytes. 2017 Chem. Phys. Lipids pmid:28322741
Karrenbauer VD et al. Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis. 2006 Clin Neurol Neurosurg pmid:16144738
Leoni V et al. Diagnostic use of cerebral and extracerebral oxysterols. 2004 Clin. Chem. Lab. Med. pmid:15061359
Solfrizzi V et al. Circulating biomarkers of cognitive decline and dementia. 2006 Clin. Chim. Acta pmid:16139826
Vega GL et al. The effects of gender and CYP46 and apo E polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins. 2004 Curr Alzheimer Res pmid:15975088
Joffre C et al. Oxysterols induced inflammation and oxidation in primary porcine retinal pigment epithelial cells. 2007 Curr. Eye Res. pmid:17453947
Jeitner TM et al. Oxysterol derivatives of cholesterol in neurodegenerative disorders. 2011 Curr. Med. Chem. pmid:21428891
Cook IT et al. 24-hydroxycholesterol sulfation by human cytosolic sulfotransferases: formation of monosulfates and disulfates, molecular modeling, sulfatase sensitivity, and inhibition of liver x receptor activation. 2009 Drug Metab. Dispos. pmid:19589875
Sodero AO et al. Cholesterol loss during glutamate-mediated excitotoxicity. 2012 EMBO J. pmid:22343944
Thelen KM et al. Effect of pravastatin on plasma sterols and oxysterols in men. 2006 Eur. J. Clin. Pharmacol. pmid:16385401
Kölsch H et al. CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism. 2009 Eur. Psychiatry pmid:19286353
Lukiw WJ Cholesterol and 24S-hydroxycholesterol trafficking in Alzheimer's disease. 2006 Expert Rev Neurother pmid:16734516
Urano Y et al. Suppression of amyloid-β production by 24S-hydroxycholesterol via inhibition of intracellular amyloid precursor protein trafficking. 2013 FASEB J. pmid:23839932
Seet RC et al. Biomarkers of oxidative damage in cigarette smokers: which biomarkers might reflect acute versus chronic oxidative stress? 2011 Free Radic. Biol. Med. pmid:21420490
Seet RC et al. Oxidative damage in dengue fever. 2009 Free Radic. Biol. Med. pmid:19427377
Virginio VW et al. Arterial tissue and plasma concentration of enzymatic-driven oxysterols are associated with severe peripheral atherosclerotic disease and systemic inflammatory activity. 2015 Free Radic. Res. pmid:25465091
Valenza M et al. Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation. 2007 Hum. Mol. Genet. pmid:17613541
Burlot MA et al. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology. 2015 Hum. Mol. Genet. pmid:26358780
Panzenboeck U et al. Regulatory effects of synthetic liver X receptor- and peroxisome-proliferator activated receptor agonists on sterol transport pathways in polarized cerebrovascular endothelial cells. 2006 Int. J. Biochem. Cell Biol. pmid:16530456
Kölsch H et al. Polymorphism in ABCA1 influences CSF 24S-hydroxycholesterol levels but is not a major risk factor of Alzheimer's disease. 2006 Int. J. Mol. Med. pmid:16596262
Freemantle E et al. Analysis of oxysterols and cholesterol in prefrontal cortex of suicides. 2013 Int. J. Neuropsychopharmacol. pmid:23369504
Fourgeux C et al. Single nucleotide polymorphism in the cholesterol-24S-hydroxylase (CYP46A1) gene and its association with CFH and LOC387715 gene polymorphisms in age-related macular degeneration. 2012 Invest. Ophthalmol. Vis. Sci. pmid:22977134
Fourgeux C et al. Primary open-angle glaucoma: association with cholesterol 24S-hydroxylase (CYP46A1) gene polymorphism and plasma 24-hydroxycholesterol levels. 2009 Invest. Ophthalmol. Vis. Sci. pmid:19553612
Mast N et al. Cholestenoic Acid is an important elimination product of cholesterol in the retina: comparison of retinal cholesterol metabolism with that in the brain. 2011 Invest. Ophthalmol. Vis. Sci. pmid:20881306
Thelen KM et al. High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels. 2006 J Clin Pharmacol pmid:16809807
Papassotiropoulos A et al. A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease. 2005 J Clin Psychiatry pmid:16013913
Kölsch H et al. Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol-17beta. 2001 J Neural Transm pmid:11475014
Sauder S et al. Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients. 2005 J Neural Transm pmid:15666037
Kölsch H et al. Polymorphism in neuropeptide Y influences CSF cholesterol levels but is no major risk factor of Alzheimer's disease. 2006 J Neural Transm pmid:15959845
Kölsch H et al. The role of 24S-hydroxycholesterol in Alzheimer's disease. 2003 J Nutr Health Aging pmid:12679839
Papassotiropoulos A et al. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. 2002 Jan-Feb J Psychiatr Res pmid:11755458
Sugimoto H et al. Method development for the determination of 24S-hydroxycholesterol in human plasma without derivatization by high-performance liquid chromatography with tandem mass spectrometry in atmospheric pressure chemical ionization mode. 2015 J Sep Sci pmid:26249017
Hughes TM et al. Brain cholesterol metabolism, oxysterols, and dementia. 2013 J. Alzheimers Dis. pmid:23076077
Wang HL et al. Cholesterol, 24-Hydroxycholesterol, and 27-Hydroxycholesterol as Surrogate Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Meta-Analysis. 2016 J. Alzheimers Dis. pmid:26836015
Hughes TM et al. Markers of cholesterol metabolism in the brain show stronger associations with cerebrovascular disease than Alzheimer's disease. 2012 J. Alzheimers Dis. pmid:22377780
Pinçon A et al. Increased susceptibility of dyslipidemic LSR+/- mice to amyloid stress is associated with changes in cortical cholesterol levels. 2015 J. Alzheimers Dis. pmid:25690661
Leoni V et al. Diagnostic power of 24S-hydroxycholesterol in cerebrospinal fluid: candidate marker of brain health. 2013 J. Alzheimers Dis. pmid:23666171
Saint-Pol J et al. Brain pericytes ABCA1 expression mediates cholesterol efflux but not cellular amyloid-β peptide accumulation. 2012 J. Alzheimers Dis. pmid:22433669
Bodin K et al. Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4. 2001 J. Biol. Chem. pmid:11514559
Bjorkhem I et al. From brain to bile. Evidence that conjugation and omega-hydroxylation are important for elimination of 24S-hydroxycholesterol (cerebrosterol) in humans. 2001 J. Biol. Chem. pmid:11463788
Meir K et al. Human sterol 27-hydroxylase (CYP27) overexpressor transgenic mouse model. Evidence against 27-hydroxycholesterol as a critical regulator of cholesterol homeostasis. 2002 J. Biol. Chem. pmid:12119285
Abildayeva K et al. 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux. 2006 J. Biol. Chem. pmid:16524875
Li-Hawkins J et al. Expression cloning of an oxysterol 7alpha-hydroxylase selective for 24-hydroxycholesterol. 2000 J. Biol. Chem. pmid:10748047
Lehmann JM et al. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. 1997 J. Biol. Chem. pmid:9013544
Breuer O and Björkhem I Use of an 18O2 inhalation technique and mass isotopomer distribution analysis to study oxygenation of cholesterol in rat. Evidence for in vivo formation of 7-oxo-, 7 beta-hydroxy-, 24-hydroxy-, and 25-hydroxycholesterol. 1995 J. Biol. Chem. pmid:7657597
Björkhem I et al. Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro. 1997 J. Biol. Chem. pmid:9374499
Mateos L et al. Side chain-oxidized oxysterols regulate the brain renin-angiotensin system through a liver X receptor-dependent mechanism. 2011 J. Biol. Chem. pmid:21628469
Brown J et al. Differential expression of cholesterol hydroxylases in Alzheimer's disease. 2004 J. Biol. Chem. pmid:15148325
Yamanaka K et al. 24(S)-hydroxycholesterol induces neuronal cell death through necroptosis, a form of programmed necrosis. 2011 J. Biol. Chem. pmid:21613228
Björkhem I Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. 2006 J. Intern. Med. pmid:17116000
Hansson M et al. Unique patient with cerebrotendinous xanthomatosis. Evidence for presence of a defect in a gene that is not identical to sterol 27-hydroxylase. 2007 J. Intern. Med. pmid:17444890